Connected Care
Discover how the FreeStyle Libre Ecosystem of products and apps connect together to help you manage your diabetes better.
Use the FreeStyle LibreLink app available on the Apple App Store or Google Play Store to scan your FreeStyle Libre 2 sensor.
The FreeStyle Libre 2 readers will be available in South Africa towards the end of 2024.
If you claim from a pharmacy not listed above, the price of each sensor may be greater than the approved CGM benefit amount, and the amount billed by pharmacy would be for your own account.
GB Mainland: 3 day delivery
Northern Ireland: 3-4 day delivery
(Estimated standard delivery)
All payments are secure and encrypted
Your cart is empty
You will now receive glucose information in the LibreLinkUp app. You do not need to have the LibreLinkUp app running to receive notifications from your connections. You can connect with up to 20 FreeStyle LibreLink app users to see their glucose readings.
If you successfully installed LibreLinkUp and set up your account, but do not see a notification from the FreeStyle LibreLink app user, make sure that your phone has an active Internet connection (Wi-Fi or mobile) and your phone settings allow you to receive notifications.
If you still do not see an invitation and you know that the invitation was sent, ask the FreeStyle LibreLink app user who invited you to send a new invitation to the email address that you used when installed LibreLinkUp.
Download the LibreLinkUp app§, connect it to your loved-one's FreeStyle LibreLink app, and you can keep up-to-date with their glucose levels, wherever they are.ǁ,Ѱ
With LibreLinkUp,§ family and caregivers get real-time access to their loved-one's glucose information and customisable alarms for peace of mind1.
FreeStyle Libre products have excellent, reliable alarm performance, especially in the low glucose range.2
When connected, parents and caregivers will be able to see their loved-one's real-time glucose levels and trends, offering the freedom to be out and about without the need for fingersticks.†
Discover how the FreeStyle Libre Ecosystem of products and apps connect together to help you manage your diabetes better.
Use our cloud-based management solution LibreView₼ as an option to stay connected to your healthcare team.
Images are for illustrative purposes only. Not real patient or data.
§ The LibreLinkUp app is only compatible with certain mobile device and operating systems. Please check www.librelinkup.com for more information about device compatibility before using the app. Use of LibreLinkUp requires registration with LibreView. The LibreLinkUp mobile app is not intended to be a primary glucose monitor: home users must consult their primary device(s) and consult a healthcare professional before making any medical interpretation and therapy adjustments from the information provided by the app.
* FreeStyle Libre apps refers to the FreeStyle LibreLink
^ Sharing of glucose data requires requires registration with LibreView. Automatic upload to LibreView requires a wireless internet connection or mobile data connection.
◊ The FreeStyle LibreLink app is only compatible with certain mobile devices and operating systems. Please check the website for more information about device compatibility before using the app. Use of FreeStyle LibreLink may require registration with LibreView.
ǁ Transfer of glucose data between applications depends on Internet connectivity.
Ѱ For children aged 4-12, a caregiver at least 18 years old is responsible for supervising, managing, and assisting them in using the FreeStyle Libre system and interpreting its readings.
† Fingersticks are required if glucose readings and alarms do not match symptoms or expectations.
₼ The LibreView data management software is intended for use by both patients and healthcare professionals to assist people with diabetes and their healthcare professionals in the review, analysis and evaluation of historical glucose device data to support effective diabetes management. The LibreView software is not intended to provide treatment decisions or to be used as a substitute for professional healthcare advice.
1. Campbell, F. Pediatric Diabetes. (2018): https://doi.org/10.1111/pedi.12735 [Accessed May 2023]
2. Shridhara Alva, Timothy Bailey, Ronald Brazg, Erwin S. Budiman, Kristin Castorino, Mark P. Christiansen, Gregory Forlenza, Mark Kipnes, David R. Liljenquist, Hanquing Liu. “Accuracy of a 14-Day Factory-Calibrated Continuous Glucose Monitoring System with Advanced Algorithm in Pediatric and Adult Population With Diabetes.” [published online ahead of print September 19, 2020]. Journal of Diabetes Science and Technology. https://doi.org/10.1177/1932296820958754 [Accessed May 2023]
Clicking the "Yes" link below will take you to a website other than Abbott Laboratories. Links that direct you to other sites are not under the control of Abbott Laboratories. Abbott Laboratories is therefore not responsible for the content of such websites or for any other links that may appear on this website. Abbott Laboratories provides these links only as a courtesy, and the inclusion of a link does not imply approval of Abbott Laboratories for this page.
Leaving Page?
This is a product-specific website exclusively for people residing in South Africa. If you live in another country, please contact your local Abbott representative to obtain the correct product information for your country of residence (click “Go to worldwide”). To visit the local site in English, click “Stay here”.
STAY CONNECTED